Want to join the conversation?
As of Sept. 30, 2015, $LH had outstanding authorization to purchase up to $789.5MM of its common stock. Following the announcement of the acquisition of Covance Inc., $LH suspended its share repurchases. It does not anticipate resuming its repurchase activity until it approaches its targeted ratio of total debt to consolidated EBITDA of 2.5 to 1.0.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.